Renaissance Technologies (RenTech)'s ANVS Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 1 M shares of Annovis Bio, Inc. (ANVS) worth $1.86 M, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in ANVS, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 654,600 shares. Largest reduction occurred in Q2 2025, reducing 21,800 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Annovis Bio (ANVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Annovis Bio (ANVS) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +654,600 | Add 188.32% | 1 M | $1.86 |
| Q1 2026 | +347,600 | New Buy | 347,600 | $2.23 |
| Q2 2025 | -21,800 | Sold Out | 0 | $0.00 |
| Q1 2025 | +21,800 | New Buy | 21,800 | $1.50 |
| Q3 2022 | -16,700 | Sold Out | 0 | $0.00 |
| Q2 2022 | -6,497 | Reduce 28.01% | 16,700 | $11.32 |
| Q1 2022 | +12,697 | Add 120.92% | 23,197 | $13.36 |
| Q4 2021 | +10,500 | New Buy | 10,500 | $17.62 |
| Q2 2021 | -19,900 | Sold Out | 0 | $0.00 |
| Q1 2021 | +19,900 | New Buy | 19,900 | $27.89 |
| Q4 2020 | -20,615 | Sold Out | 0 | $0.00 |
| Q3 2020 | +20,615 | New Buy | 20,615 | $4.80 |
Renaissance Technologies (RenTech)'s Annovis Bio Investment FAQs
Renaissance Technologies (RenTech) first purchased Annovis Bio, Inc. (ANVS) in Q3 2020, acquiring 20,615 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Annovis Bio, Inc. (ANVS) for 12 quarters since Q3 2020.
Renaissance Technologies (RenTech)'s largest addition to Annovis Bio, Inc. (ANVS) was in Q2 2026, adding 1,002,200 shares worth $1.86 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 1,002,200 shares of Annovis Bio, Inc. (ANVS), valued at approximately $1.86 M.
As of the Q2 2026 filing, Annovis Bio, Inc. (ANVS) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Annovis Bio, Inc. (ANVS) was 1,002,200 shares, as reported at the end of Q2 2026.